Decera Clinical Education

Treatment Options and Considerations for Newly Diagnosed HER2+ Metastatic Breast Cancer: A Resource for Patients and Caregivers Download this brief resource for patients and their caregivers with key information and considerations regarding treatment options for newly diagnosed HER2-positive metastatic breast cancer.

A new diagnosis brings questions. This ✨ free ✨ downloadable PDF provides patients and caregivers with clear, accessible information about treatment options for newly diagnosed HER2-positive metastatic breast cancer.

📥 Download the resource: https://bit.ly/4cOhVWn

The Dermatologist’s Guide to Recognizing Systemic Mastocytosis Download this resource for dermatology healthcare professionals for a brief overview of recognizing the cutaneous manifestations of systemic mastocytosis.

Skin clues can signal systemic disease. This quick guide helps dermatology HCPs recognize the cutaneous manifestations of systemic mastocytosis and support earlier diagnosis.

📄 Access here: https://bit.ly/3ZFmNpa

#Dermatology #MedEd

A new rhythm in ASCVD risk reduction 🎶Join Viet Le, DMSc, MPAS, PA-C, FACC, FAHA, HF-Cert, and colleagues for an interactive Master Class covering lipoprotein(a) testing, personalized lipid-lowering strategies, and real-world barriers to guideline-directed care.
👉 Register: https://bit.ly/4aBDE1d

📅 Events This Week | Earn FREE CME

We have several virtual programs happening this week, featuring expert faculty and timely, evidence-based discussions across key therapeutic areas.

View the full schedule & register: https://bit.ly/4aQd9VO

👋 Join us live, we’d love to see you there!

A therapeutic revolution in diabetic kidney disease set the stage for today’s CKM innovations. Experts explain how RAAS inhibition changed care & why compensatory aldosterone activity can limit long term impact, driving the need for newer CKM-targeted approaches

▶️ Watch here: https://bit.ly/49ZSUEL

Our Winter 2026 Genitourinary Oncology events are well underway, and the momentum continues. 👏
🎉 More sessions are happening tonight and tomorrow.

If you’re joining us, we look forward to continuing the conversation: https://bit.ly/49W3spJ

#ASCOGU #GenitourinaryOncology #CME #MedicalEducation

Immunotherapy is reshaping care in cutaneous squamous cell carcinoma. Explore our Clinical Focus module covering neoadjuvant & adjuvant strategies, surgical considerations, and multidisciplinary management in advanced cSCC.

👉 Access the activity: https://bit.ly/3Zuya3d

#MedicalEducation #CME

Therapeutic innovation is reshaping how we treat CKD, heart failure, and metabolic disease—together. 💓🗣️

Experts highlight emerging evidence behind GLP-1–based and dual incretin therapies and their impact on cardiovascular and renal outcomes.

▶️ Watch the full expert video: https://bit.ly/49ZSUEL

Expert Conversations in Systemic Mastocytosis: Clinical Insights for Dermatology Professionals Expert-curated slides on the dermatologist’s role in diagnosing and managing care for patients with systemic mastocytosis (SM), including the latest advances on treating symptoms and employing targete...

Expert insights on diagnosing and managing systemic mastocytosis, tailored for dermatology professionals.

✨ Download the slideset for your own practice: https://bit.ly/46nD7hV

#SystemicMastocytosis #DermatologyEducation #ClinicalInsights

Answer below, then watch the full certified on-demand webcast. An expert shares practical strategies for managing key antibody–drug conjugate toxicities, highlighting supportive care, dose adjustments, and patient education to support adherence and outcomes.

💻 Watch here: https://bit.ly/4akGoRr

How are HCPs approaching cognitive care in everyday practice? Decera Clinical learners share real-world insights on what works, what’s missing, and what’s next.

Read the Clinical Thought: https://bit.ly/3NW7Jke

From scientific discovery to clinical decision-making. Michelle Kittleson, MD, PhD, Katherine Tuttle, MD, & Stefano Del Prato, MD, reflect on how decades of cross-disciplinary research are shaping CKM care.

▶️ Watch full video: https://bit.ly/49ZSUEL

Case Challenge: Personalizing Care in HR+/HER2- Metastatic Breast Cancer

▶️ Explore the case and test your clinical approach: https://bit.ly/3Zovtjq

#CME #OncologyEducation

Barriers to Optimal Care and Educational Opportunities for European Physicians Treating Patients With Relapsed/Refractory (R/R) CLL This poster, presented at the 2025 ASH annual meeting, features data from an online educational program and details educational opportunities for European physicians in treating R/R CLL; variance in how physicians in different European countries manage ...

Barriers to Optimal Care and Educational Opportunities for European Physicians Treating Relapsed/Refractory (R/R) CLL

📄 Download the free PDF to explore the insights and implications for clinical practice: https://bit.ly/4bKu12k

From conference data to clinical impact. Amir T. Fathi, MD shares key leukemia takeaways from American Society of Hematology 2025, highlighting what new data may mean for patients with AML and CML.

🎧 Listen to the full discussion:https://bit.ly/3NN1bUW

#ASH25 #MedicalEducation

Real-world MASH care goes beyond initial treatment decisions. This Clinical Thought explores ongoing challenges in long-term MASH management, and how new data and updated guidelines are reshaping sustained success.
👇 Share your answer
📖 Read the full Clinical Thought https://bit.ly/3MLuZB5

Early recognition matters in fibrosing ILDs. Expert faculty break down key risk factors and best practices to support timely diagnosis in real-world care.

💥 Watch Fibrosing ILDs on the Frontlines (on-demand)
💥 Earn CE/CME: https://bit.ly/48M4WCs

IV iron during acute infection remains debated.
New real-world evidence suggests IV iron use in patients with iron deficiency anemia and acute infection was associated with improved survival and hemoglobin recovery.

📊 Explore the conference slideset for full details: https://bit.ly/4j0hBVP

Join Rachna Shroff, MD, MS, FASCO at an ASCO GI 2026 satellite symposium exploring HER2-positive GI cancers, from molecular testing to targeted therapy across gastric/GEJ, CRC, and biliary tract cancers.

👉 Register: https://bit.ly/48FksQl

#ASCOGI2026 #HER2 #GICancers

The role of HER2 in advanced bladder cancer is rapidly expanding.

📖 Read the full clinical thought commentary for expert perspectives on testing strategies, treatment sequencing, and future directions in HER2-positive urothelial carcinoma: https://bit.ly/4pIHX11

#HER2 #BladderCancer

Artificial Intelligence in Cardiovascular Care: Foundations and Best Practices for Improving Patient Outcomes Five cardiology experts discuss the foundations of artificial intelligence in healthcare and best practices for developing and implementing these technologies to enhance the care of patients with suspected or established cardiovascular disease.

AI is helping clinicians interpret more, faster, supporting greater access at the point of care.

New text module! Artificial Intelligence in Cardiovascular Care

👉 Download to access expert insights and earn CE/CME: https://bit.ly/48M3cYC

What’s changing in HER2 testing and how it should it guide #GIcancercare in 2026?
Expert faculty break down HER2 testing and targeted therapy across gastric/GEJ, CRC, and BTC at ASCO GI 2026.

📅 Jan 9 | In-person + virtual

👉 https://bit.ly/48FksQl

HER2 #ASCOGI2026

What stood out in leukemias at #ASH25?

In this PulseCast episode, Amir T. Fathi, MD, reviews key studies and discusses how emerging data may inform care for patients with AML and CML.

Listen to the full episode here: https://bit.ly/4p4m9vM

CLL17: Phase III Trial of Continuous Ibrutinib vs Fixed-Duration Venetoclax Plus Obinutuzumab or Venetoclax Plus Ibrutinib for Untreated CLL Data from the phase III CLL17 study demonstrate noninferior PFS with fixed-duration venetoclax plus obinutuzumab or venetoclax plus ibrutinib vs continuous ibrutinib among patients with untreated CLL ...

New ASH 2025 analysis: CLL17 (Phase III)
Fixed-duration venetoclax + obinutuzumab or venetoclax + ibrutinib showed noninferior PFS vs continuous ibrutinib in untreated CLL.
Slideset 👉 https://bit.ly/3XW6Qdu

#CLL #Hematology

How can real-world clinician insights improve education design?
This PDF explores a community-informed, multimodal program supporting patient-centered care in myelofibrosis with JAK inhibitors.

📄 https://bit.ly/4qeLy6U

#Myelofibrosis #Hematology #MedicalEducation

HER2 in Context in NSCLC, Testing Strategies and Advances in Methodologies, and a Brief Review of ADCs in NSCLC Downloadable slides on the role of HER2 in NSCLC, testing strategies and advances in methodologies, and a brief review of the utility of ADCs in NSCLC

Understanding HER2 in NSCLC continues to evolve.

This downloadable slideset reviews:
✔ HER2 biology and relevance in NSCLC
✔ Testing approaches and emerging methodologies
✔ An overview of ADCs and their clinical utility

Access the slides here: https://bit.ly/4rVKypI

#HER2Testing #CME

Obesity treatment is a team sport. ✨ From primary care providers and specialists to mental health professionals, physical therapists, and dietitians, each role can make a difference in a patient’s long-term success. Watch our new medical minute:. https://bit.ly/3KR5QE1

#MedicalEducation #CME

AI is already reshaping cardiovascular care, from imaging reconstruction to diagnostic and monitoring assistance. 💗

When clinicians know how to interpret outputs, AI can support clearer decisions and earlier insights.

👉 Learn more and earn CE/CME: https://bit.ly/48M3cYC

What a wonderful two days at the 11th Annual Psychopharmacology Update 2025 🧠
Thank you to our expert faculty and all the clinicians who joined us.

Explore event resources and upcoming programs 👉 https://bit.ly/44sEqva

#CME #MedicalEducation #PsychiatricCare

Join Matthew Gubens, MD, MS, FASCO and Estelamari Rodriguez, MD, MPH this Tuesday for a 1-hour expert discussion on the latest insights in HER2-altered NSCLC.

A concise, practical session designed to support real-world decision-making 👉 https://bit.ly/451c6QE

#MedicalEducation #CME #NSCLC #HER2